Afficher la notice abrégée

Antiparasitic activity against trypanosomatid diseases and novel metal complexes derived from the first time characterized 5-phenyl-1, 2, 4-triazolo [1, 5-a] pyrimidi-7 (4H)-one

dc.contributor.authorMendez-Arriaga, Jose Manuel
dc.contributor.authorEsteban-Parra, Gines Miguel
dc.contributor.authorJuarez, Maria Jose
dc.contributor.authorRodríguez-Diéguez, Antonio
dc.contributor.authorSanchez-Moreno, Manuel
dc.contributor.authorIsac-García, Joaquin
dc.contributor.authorSalas, Juan Manuel
dc.date.accessioned2024-02-07T11:17:11Z
dc.date.available2024-02-07T11:17:11Z
dc.date.issued2017-10-01
dc.identifier.citationJournal of Inorganic Biochemistry 175 (2017) 217–224es
dc.identifier.issn0162-0134
dc.identifier.issn1873-3344
dc.identifier.urihttps://hdl.handle.net/10115/29879
dc.description.abstractA serie of isostructural complexes with general formula [M(ftpO)2(H2O)4] have been obtained from reaction between the first time characterized triazolopyrimidine derivative 5-phenyl-1,2,4-triazolo[1,5-a]pyrimidi-7(4H)-one (HftpO) (1) and first row transition nitrates (M = Cu (2), Co (3), Ni (4) and Zn (5)). A copper complex with formula [Cu(HftpO)2(NO3)2(H2O)2]· H2O (6) was also isolated. HftpO and their metal complexes have been characterized by spectroscopic and thermal analysis and their crystal structures have been solved by X-ray diffraction methods. The isostructural compounds are mononuclear complexes where the triazolopyrimidine ligand acts as monodentate ligand through N3 nitrogen position. The crystal structure of these novel bis-5-phenyl-1,2,4-triazolo[1,5-a]pyrimidin-7(4H)-one-tetraaquo metal complexes offers an excellent opportunity at these complexes to acts as potential building blocks. Also, the antiparasitic activity of HftpO ligand against different leishmania and trypanosome strains has been studied.es
dc.language.isoenges
dc.publisherElsevieres
dc.rightsAttribution-NonCommercial-NoDerivs 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleAntiparasitic activity against trypanosomatid diseases and novel metal complexes derived from the first time characterized 5-phenyl-1, 2, 4-triazolo [1, 5-a] pyrimidi-7 (4H)-onees
dc.typeinfo:eu-repo/semantics/articlees
dc.identifier.doi10.1016/j.jinorgbio.2017.07.026es
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses


Fichier(s) constituant ce document

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

Attribution-NonCommercial-NoDerivs 4.0 InternationalExcepté là où spécifié autrement, la license de ce document est décrite en tant que Attribution-NonCommercial-NoDerivs 4.0 International